Delisted on April 7, 2026 — historical financial data only. Live prices, news, and estimates are unavailable.
Citable segment mix
HOLX's latest SEC segment disclosure for revenue by segment shows Breast Health as the largest listed segment at $219.90M (50.1% of disclosed segment revenue).
| Segment | Period | Revenue | Mix |
|---|---|---|---|
| Breast Health | Dec 27, 2025 | $219.90M | 50.1% |
| GynSurgical | Dec 27, 2025 | $128.90M | 29.4% |
| Diagnostics | Dec 27, 2025 | $76.00M | 17.3% |
| Skeletal Health | Dec 27, 2025 | $13.80M | 3.1% |
Source: SEC EDGAR segment disclosures; period Dec 27, 2025.
Continue research
Follow same-sector companies and source explainers connected to the segments view.
A factual guide to revenue segment disclosures and how Aerarium Research uses them to make company business mix easier to inspect.
A factual guide to seasonal revenue patterns and comparable (same-store) sales — why year-over-year comparisons matter and what comp sales strip out.
A factual guide to deferred revenue, cash collected before revenue is earned, and why the liability can matter for recurring businesses.
A factual guide to quarterly SEC Form 10-Q reports, how they differ from annual 10-K filings, and what readers can inspect first.
